SEC Tracker
Get the app

Adaptin Bio APTN

Adaptin Bio, Inc., a Lucius Partners Portfolio Company

Form
8-K
Filed
Period
Importance
Routine
Document
8-K
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Adaptin Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Artelo Biosciences ARTL public float $9M, Jun 30, 2025
  2. Bioxytran BIXT public float $9M, Jun 30, 2025
  3. Raphael Pharmaceutical RAPH public float $9M, Jun 30, 2025
  4. Oncotelic Therapeutics OTLC public float $9M, Jun 30, 2025
  5. TherapeuticsMD TXMD public float $9M, Jun 30, 2025